Watch Ticker

Adlai Nortye Ltd. American Depositary Shares

Go to Adlai Nortye Ltd. American Depositary Shares Website

$1.45

-0.05 (-3.33%)

Live

Previous Close

$1.5

Day Range

$1.43 - $1.55

Previous Day Range

$1.43 - $1.52

Market Cap

$53.5 million USD

Day Vol.

5779

Previous Day Vol.

8799

Currency

USD

Primary Exchange

None

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (A...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Adlai Nortye Ltd. - Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will present encouraging preliminary data of AN0025 in combination with definitive chemoradiotherapy (dCRT) in unresectable locally advanced or locally recurrent esophageal cancer (EC) at the upcoming American Society of Cancer Oncology (ASCO) Annual Meeting to be held in Chicago from May 31 to June 4, 2024.

Related tickers: ANL.

Read Full Article

Zacks Equity Research - Are Medical Stocks Lagging Adlai Nortye Ltd. Sponsored ADR (ANL) This Year?

Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Boston Scientific (BSX) have performed compared to their sector so far this year.

Related tickers: ANL, BSX.

Read Full Article

Trending Tickers

Please sign in to view